Procter & Gamble has agreed to acquire science-focused wellness supplements company Thorne in a deal valued at $3.8 billion. The acquisition expands PG into premium health and wellness categories, specifically vitamins, minerals, and supplements, extending its existing health portfolio. Thorne brings a focused portfolio of science-backed supplements that will sit alongside PG brands like Metamucil and Align. The move pushes the consumer goods giant further into preventative health spending, a space where competitors such as Nestlé and Unilever are also active. Investors will watch for updates on integration milestones, financial impact, and how PG manages its balance sheet given an existing flagged risk around high debt levels.
Procter & Gamble CompanyAcquires Thorne for $3.8B, expanding into premium supplements.
Nestle S.A.
Unilever PLC
Unilever PLCAcquired by P&G at $3.8B, providing exit for shareholders.